刺五加注射液对大鼠肝微粒体四种CYP450亚型酶活性的影响

被引:17
作者
曾超
刘艳
刘高峰
李想
机构
[1] 哈尔滨医科大学附属第二医院药学部黑龙江省高校重点实验室
基金
黑龙江省自然科学基金;
关键词
刺五加注射液; CYP450酶; 探针药物; 肝微粒体法; 抑制作用;
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
摘要
目的:研究刺五加注射液在大鼠体外肝微粒体中对CYP2C9、CYP2D6、CYP2E1和CYP3A4活性的影响,为临床合理联合用药提供参考。方法:在大鼠体外肝微粒体中分别加入四种亚型酶的探针药物甲苯磺丁脲(TB)、右美沙芬(DM)、氯唑沙宗(CLZ)、睾酮(TS)和低、中、高剂量的刺五加注射液,温孵后用HPLC法测定各空白对照组和不同剂量刺五加注射液给药组中各探针药物代谢产物的浓度并比较代谢率的差异,以评价刺五加注射液对各亚型酶活性的影响;中剂量组活性显著降低的亚型酶进一步考察抑制作用的强弱(即IC50和Ki值)。结果:与空白对照组比较,刺五加注射液低、中、高剂量给药组对CYP3A4活性的影响均有统计学意义(P<0.01),抑制率分别为10.22%、19.00%、30.29%,其IC50和Ki值分别为3.96%和2.74%(V/V);低、中、高剂量给药组对CYP2D6活性的影响均无统计学差异(P>0.05);低剂量给药组对CYP2C9、CYP2E1活性的影响无统计学差异(P>0.05),中、高剂量给药组对两个亚型的抑制作用有统计学差异(P<0.05),但中剂量给药组抑制率均小于8.50%,高剂量给药组抑制率均小于12.00%。结论:刺五加注射液对大鼠体外肝微粒体CYP3A4有抑制作用,且符合混合型抑制模型;对CYP2C9、CYP2E1抑制作用较弱;对CYP2D6活性无影响。
引用
收藏
页码:164 / 170
页数:7
相关论文
共 24 条
  • [1] 中国国家处方集.[M].《中国国家处方集》编委会; 编写.人民军医出版社.2010,
  • [2] 生物化学.[M].王镜岩等主编;.高等教育出版社.2002,
  • [3] Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro
    Wang, Xin
    Cheung, Ching Mei
    Lee, Wayne Y. W.
    Or, Penelope M. Y.
    Yeung, John H. K.
    [J]. PHYTOMEDICINE, 2010, 17 (11) : 868 - 875
  • [4] In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica
    Pan, Yan
    Abd-Rashid, Badrul Amini
    Ismail, Zakiah
    Ismail, Rusli
    Mak, Joon Wah
    Pook, Peter C. K.
    Er, Hui Meng
    Ong, Chin Eng
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2010, 130 (02) : 275 - 283
  • [5] Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicin
    Babbar, Sunita
    Chanda, Sanjay
    Bley, Keith
    [J]. XENOBIOTICA, 2010, 40 (12) : 807 - 816
  • [6] Inhibition and induction of human cytochrome P450 enzymes: current status
    Pelkonen, Olavi
    Turpeinen, Miia
    Hakkola, Jukka
    Honkakoski, Paavo
    Hukkanen, Janne
    Raunio, Hannu
    [J]. ARCHIVES OF TOXICOLOGY, 2008, 82 (10) : 667 - 715
  • [7] Quercetin pretreatment increases the bioavailability of pioglitazone in rats: Involvement of CYP3A inhibition
    Umathe, Sudhir N.
    Dixit, Pankaj V.
    Kumar, Vijendra
    Bansod, Kuldeep U.
    Wanjari, Manish M.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2008, 75 (08) : 1670 - 1676
  • [8] Studying cytochrome P450 kinetics in drug metabolism
    Kramer, Melissa A.
    Tracy, Timothy S.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (05) : 591 - 603
  • [9] In Vitro Evaluation of Reversible and Irreversible Cytochrome P450 Inhibition: Current Status on Methodologies and their Utility for Predicting Drug–Drug Interactions
    Stephen Fowler
    Hongjian Zhang
    [J]. The AAPS Journal, 2008, 10 : 410 - 424
  • [10] A novel testosterone 6β-hydroxylase activity assay for the study of CYP3A-mediated metabolism; inhibition; and induction in vitro.[J].Jessica L Fayer;David M Petullo;Barbara J Ring;Steven A Wrighton;Kenneth J Ruterbories.Journal of Pharmacological and Toxicological Methods.2002, 2